Covid-19 monoclonal antibody IV therapy
We now offer Monoclonal Antibody IV Therapy to treat patients who have tested positive for Covid-19 and have mild to moderate symptoms and to prevent severe symptoms in patients who meet certain criteria.
Monoclonal Antibody IV therapy
Monoclonal antibodies are a new type of IV treatment that support the body’s immune system and help fight a Covid-19 infection by reducing the amount of SARS-CoV-2 in a person’s body. This treatment is especially valuable in individuals who are immunocompromised or are taking immunosuppressants or have a medical condition that puts them at a high risk of developing complications.
Monoclonal antibodies can help:
- Prevent symptoms from becoming severe enough to require hospitalization
- Reduce the viral load in the body, reducing the severity of symptoms
- Shorten the recovery timeline
$1,999
Who is eligible to receive monoclonal antibody IV therapy?
Monoclonal antibody treatments are available for individuals who:
- Have tested positive for Covid-19
- Have been exposed to Covid-19
- Have mild to moderate symptoms
- Are vaccinated OR unvaccinated
- Are in high-risk environments
- Are immunocompromised
- Are taking immunosuppressants
- Are at high risk for developing complications
Frequently Asked Questions
Who is not eligible for this treatment?
Individuals are NOT eligible for this treatment if they are:
- Currently hospitalized for Covid-19
- Requiring oxygen therapy due to Covid-19
- Allergic to any of the ingredients in the treatment
- Not showing any symptoms of Covid-19
- Outside of the 10-day window since the start of symptoms and positive test result
How long does it take?
The monoclonal antibody IV infusion takes about 20-30 minutes. Afterwards, patients can expect to be monitored for approximately one hour to ensure that they do not exhibit an allergic reaction or other adverse effects. The entire process takes 2 hours.
Are there any side effects?
IV therapy in general is a minimally invasive medical procedure. Most side effects will be related to the IV procedure itself and may include:
- Redness, tenderness, or swelling at the injection site
- Minor bruising or swelling at the injection site
- Infection (rare)
In addition to these symptoms, it is also possible for some patients to experience an allergic reaction to the ingredients in the infusion. Allergic reactions generally occur during or shortly after the infusion, which is why one of our nurses stays onsite to monitor patients during this time period.
- Fever and/or chills
- Nausea
- Headache
- Shortness of breath or wheezing
- Low blood pressure
- Swelling of the lips, face or throat
- Muscle aches
- Hives or itchiness
Reactions to a monoclonal antibody IV may be delayed, so it’s important to contact your doctor if you notice any of the signs of an allergic reaction listed above.
How will I receive monoclonal antibody treatment?
Monoclonal antibody treatment is administered intravenously directly into your bloodstream using a catheter and needle.
Do I have to test positive for COVID first?
Currently, monoclonal antibody treatment can only be used for people who meet certain eligibility criteria:
- High-risk individuals who have tested positive for Covid-19
- As a preventive measure in individuals who are at high-risk of developing complications from Covid-19
Is this treatment what President Trump had?
Yes. Former president Trump received monoclonal antibody treatment alongside several other Covid-19 therapies.
